Monitoring Level of Hypnosis Using Stationary Wavelet Transform and Singular Value Decomposition Entropy With Feedforward Neural Network
Sign Up to like & getrecommendations! Published in 2023 at "IEEE Transactions on Neural Systems and Rehabilitation Engineering"
DOI: 10.1109/tnsre.2023.3264797
Abstract: Classifying the patient’s depth of anesthesia (LoH) level into a few distinct states may lead to inappropriate drug administration. To tackle the problem, this paper presents a robust and computationally efficient framework that predicts a… read more here.
Keywords: neural network; stationary wavelet; loh; wavelet transform ... See more keywords
Abstract A074: Correlation of homologous recombination deficiency (HRD) status by BROCA-HR sequencing with response to combination cediranib and olaparib in relapsed ovarian cancer
Sign Up to like & getrecommendations! Published in 2019 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.targ-19-a074
Abstract: Background: The combination of cediranib (ced) and olaparib (olap) improves progression-free survival and overall response rates (ORR) in women with recurrent plat sensitive high-grade serous (HGS) ovarian cancer compared to olap alone. In this Phase… read more here.
Keywords: status; plat sensitive; hrd; cancer ... See more keywords
Adaptation by Loss of Heterozygosity in Saccharomyces cerevisiae Clones Under Divergent Selection
Sign Up to like & getrecommendations! Published in 2019 at "Genetics"
DOI: 10.1534/genetics.119.302411
Abstract: Loss of heterozygosity (LOH) is observed during vegetative growth and reproduction of diploid genotypes through mitotic crossovers, aneuploidy caused by nondisjunction, and gene conversion. We aimed to test the role that LOH plays during adaptation… read more here.
Keywords: adaptation; loh; saccharomyces cerevisiae; loss heterozygosity ... See more keywords
TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
Sign Up to like & getrecommendations! Published in 2019 at "World Journal of Gastrointestinal Oncology"
DOI: 10.4251/wjgo.v11.i7.551
Abstract: BACKGROUND Patients with stage II-III colorectal cancer (CRC) treated with adjuvant chemotherapy, gain a 25% survival benefit. In the context of personalized medicine, there is a need to identify patients with CRC who may benefit… read more here.
Keywords: kras braf; loh; risk; adjuvant chemotherapy ... See more keywords